Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Mabvinra 40 mg PFS
Manufacturer/Marketed By : Alkem Laboratories Ltd
$271.97 $212.13
Mabvinra 40 mg pre-filled syringe (PFS) is an innovative medication designed to manage various inflammatory conditions such as ankylosing spondylitis, rheumatoid arthritis, psoriasis, ulcerative colitis, and Crohn's disease. This powerful...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
Adalimumab 40 mg
Active Pharmaceutical Ingredient
Mabvinra 40 mg PFS
$271.97
$212.13
Mabvinra 40 mg pre-filled syringe (PFS) is an innovative medication designed to manage various inflammatory conditions such as ankylosing spondylitis, rheumatoid arthritis, psoriasis, ulcerative colitis, and Crohn's disease. This powerful disease-modifying anti-rheumatic drug utilizes a monoclonal antibody mechanism to effectively inhibit tumor necrosis factor-alpha (TNFα), a key player in inflammation. By blocking TNFα, Mabvinra significantly alleviates symptoms like swelling, pain, and redness, ultimately enhancing the overall quality of life for patients. While this treatment is highly effective, it's essential to be aware of potential side effects and contraindications, including an increased risk of infections. Patients are advised to discuss their medical history with healthcare providers before starting therapy. With Mabvinra, individuals can experience improved physical function and a greater sense of well-being. Always consult with a healthcare professional for personalized advice and to ensure this treatment aligns with your health needs.
Active Pharmaceutical Ingredient
Uses
• Mabvinra 40 mg pfs is primarily used to manage rheumatoid arthritis, a condition characterized by chronic inflammation of the joints. It helps reduce pain and swelling, enabling patients to maintain better mobility. By targeting the underlying inflammation, Mabvinra 40 mg pfs can improve the quality of life for those affected by this debilitating disease. Regular administration can lead to significant symptom relief and functional improvement.
• Another important application of Mabvinra 40 mg pfs is in the treatment of ankylosing spondylitis. This inflammatory disease affects the spine and can lead to severe discomfort and rigidity. Mabvinra 40 mg pfs works by modulating the immune response, helping to alleviate the symptoms and improve spinal flexibility. Patients often experience enhanced daily functioning with consistent use of this medication.
• Mabvinra 40 mg pfs is also effective for managing inflammatory bowel diseases such as Crohn's disease and ulcerative colitis. These conditions can cause significant gastrointestinal distress and other complications. By utilizing Mabvinra 40 mg pfs, patients may achieve better control over their symptoms, reducing flare-ups and improving overall gut health. This treatment plays a crucial role in enabling individuals to lead more normal lives despite their conditions.
• In addition to its use for arthritis and bowel diseases, Mabvinra 40 mg pfs is indicated for conditions like hidradenitis suppurativa and plaque psoriasis. These skin conditions can cause painful lesions and inflammation. Mabvinra 40 mg pfs helps to reduce the severity and frequency of flare-ups, allowing for clearer skin and improved comfort. Patients often report a significant enhancement in their skin health and overall well-being when using this medication.
Benefits
Rheumatoid arthritis: Rheumatoid arthritis (RA) is a chronic autoimmune disease that primarily affects the joints. It causes inflammation, pain, stiffness, and swelling in the joints and can also affect other parts of the body, such as the skin, eyes, lungs, heart, and blood vessels. Mabvinra 40 mg PFS helps reduce inflammation and manage the symptoms of rheumatoid arthritis.
Ankylosing spondylitis: Ankylosing spondylitis (AS) is a chronic inflammatory disease that primarily affects the spine, causing pain, stiffness, and reduced mobility. It is a form of arthritis that mainly affects the joints between the vertebrae in the spine and the sacroiliac joints where the spine connects to the pelvis. Adalimumab Injection 40 mg works by targeting and inhibiting tumor necrosis factor (TNF), a protein involved in inflammation. By reducing the inflammation associated with ankylosing spondylitis, Mabvinra 40 mg PFS can help relieve pain, stiffness, and other symptoms of the condition.
Crohn's disease: Crohn's disease is a chronic inflammatory bowel disease (IBD) that primarily affects the gastrointestinal tract. It can cause inflammation and damage to any part of the digestive system, from the mouth to the anus. Symptoms of Crohn's disease can vary but commonly include abdominal pain, diarrhea, weight loss, fatigue, and loss of appetite. Mabvinra PFS works by targeting and inhibiting tumor necrosis factor (TNF), a protein involved in inflammation. By reducing inflammation in the gastrointestinal tract, Mabvinra 40 mg PFS can help manage the symptoms of Crohn's disease, including abdominal pain, diarrhea, and inflammation.
Ulcerative colitis: Ulcerative colitis is a chronic inflammatory bowel disease that primarily affects the colon and rectum. Adalimumab Injection 40 mg can help reduce inflammation in the gastrointestinal tract and manage the symptoms of ulcerative colitis.
Hidradenitis suppurativa: Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition that affects the hair follicles in areas of the body with a high concentration of sweat glands, such as the armpits, groin, and buttocks. Mabvinra 40 mg works by targeting and inhibiting tumor necrosis factor (TNF), a protein involved in inflammation. By reducing inflammation, Mabvinra 40 mg PFS can help alleviate symptoms and prevent the progression of hidradenitis suppurativa.
Juvenile idiopathic arthritis: Juvenile idiopathic arthritis (JIA) is a type of arthritis that occurs in children under the age of 16 and persists for at least six weeks. It is characterized by joint inflammation, pain, stiffness, and swelling. Anti-inflammatory Drug Mabvinra works by inhibiting tumor necrosis factor (TNF), a protein involved in inflammation. By reducing inflammation in the joints, adalimumab helps manage the symptoms of juvenile idiopathic arthritis, including pain, stiffness, and swelling.
Plaque psoriasis: Psoriasis is a condition where the skin cells in the body grow too quickly and form scales and dry patches. They can grow anywhere, but most appear on the scalp, elbows, knees, and lower back. Adalimumab Injection 40 mg reduces the scaly, itchy patches that may develop on the different parts of the body. It may take several months to become fully effective. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated.
Psoriatic arthritis: Psoriatic arthritis is a type of inflammatory arthritis that occurs in some individuals with psoriasis, a chronic skin condition. It causes joint pain, swelling, and stiffness and can affect any joint in the body. Mabvinra 40 mg PFS works by inhibiting tumor necrosis factor (TNF), a protein involved in inflammation. By reducing inflammation in the joints, adalimumab can help manage the symptoms of psoriatic arthritis, including joint pain, stiffness, and swelling.
Uveitis: Uveitis refers to the inflammation of the uvea, which is the middle layer of the eye. It can affect various parts of the uvea, including the iris, ciliary body, and choroid. Anti-inflammatory Drug Mabvinra is a tumor necrosis factor (TNF) inhibitor that helps reduce inflammation by targeting TNF, a protein involved in the immune response.
Side Effects
As with all medicines, Anti-inflammatory Drug Mabvinra may cause side effects that do not require medical attention and that will disappear as your body adjusts to the medicine. If they persist or you're concerned about them, tell your doctor.
Most Common Side Effects
• Headache
• Rashes
• Sinusitis
• Nausea
• Fever
• Itching
• uneasiness
• Urinary tract infection
• Red scaly patches
• Tingling and Numbness
• Vision problems
• limb weakness
• Respiratory distress
• Chest pain hives
• sore throat
• Pale skin
• Dizziness
Common Side Effects
• Irregular heartbeats
• Heart failure (symptoms
• rapid breathing, pedal oedema, tachypnea)
• Muscle weakness
• Difficulty in movements like speaking, chewing, swallowing
• Vision changes
• Altered liver function, especially in those people who are exposed to Hepatitis B virus
How To Use
Mabvinra 40 mg PFS is given subcutaneously (under the skin) from any health care professional. Dosage and frequency will be decided by your doctor as per your disease condition and several other factors.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Mabvinra PFS. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Patients with kidney disease should closely monitor kidney function while taking Mabvinra 40 mg PFS and report any unusual symptoms or changes in kidney function to their physician. The dose of Mabvinra 40 mg should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.
• Breastfeeding: Mabvinra 40 mg is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
• Liver: Mabvinra 40 mg PFS should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Anti-inflammatory Drug Mabvinra and report any unusual symptoms or changes in liver function to their doctor. The dose of Mabvinra PFS may need to be adjusted in patients with liver disease.
• Pregnancy: Adalimumab Injection 40 mg is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects on the developing baby; however, there are limited human studies.
• Driving: Mabvinra 40 mg PFS may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions, such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Mabvinra PFS.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.